Filter by: patients
What is Rifampin?

Rifampicin is typically used to treat Mycobacterium infections, including the tuberculosis and leprosy; it also has a role in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in combination with fusidic acid.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Bartonella Infection 3 0
Other 2 0
Progressive Familial Intrahepatic Cholestasis 1 1 Efficacy_major
Infection 1 0
Participate in clinical trial 1 0
Latent tuberculosis infection 1 1 Efficacy_cant_tell

See all 9 patients currently taking Rifampin

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
2
Moderate
0
Mild
0
None
2

Commonly reported side effects, conditions, and hospitalizations associated with Rifampin

Headaches 1

Reported Dosages

  100 mg daily 150 mg daily 600 mg daily 1,200 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 6 Number of Patients: 6 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Rifampin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2   Side effects too severe: 50%
Course of treatment ended 2   Course of treatment ended: 50%

See all 4 patients who’ve stopped taking Rifampin

Currently Taking Rifampin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Stopped Taking Rifampin

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Rifampin

Always
4 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Rifampin

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
4 100%

Cost

Paid out of pocket

Cost of Rifampin

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 11, 2012.